Drug Profile
Factor Xa inhibitor - Bio-Technology General
Alternative Names: FactorexLatest Information Update: 14 Jan 2022
Price :
$50
*
At a glance
- Originator American Red Cross; Yissum Research Development Company
- Developer Nonindustrial source; Savient Pharmaceuticals
- Class
- Mechanism of Action Factor Xa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arterial occlusive disorders; Deep vein thrombosis; Thrombosis